Wintrust Business Minute: UChicago Medicine and Argonne National team up to use A.I. for drug-resistant cancer research

Wintrust Business Lunch

Steve Grzanich has the business news of the day with the Wintrust Business Minute.

Two Chicago area powerhouses in science and medicine are teaming up to use artificial intelligence to find new treatments for drug-resistant cancer. UChicago Medicine and Argonne National Laboratory will work together on the project. Researchers at University of Chicago Medicine Comprehensive Cancer Center will use Argonne’s artificial intelligence and high-performance computing to screen billions of molecules in the search for new treatments. UChicago Medicine says the goal is to find a treatment that slows or stops the growth of tumors that don’t respond to current medications. They’re hoping AI accelerates discovery.

Also, an update on the E. coli outbreak linked to McDonald’s. Listen for more below:

https://serve.castfire.com/audio/7074858/7074858_2024-11-15-192858.64kmono.mp3

Recent Posts

Wintrust Business Lunch

Tariff impact, LightQuest, Santa for a Day

.cls-7{fill:#fff;fill-rule:evenodd}

UChicago Medicine and Argonne National team up

.cls-4{fill:#000;}

Illinois up 15% in corporate relocation and expansion

.cls-4{fill:#000;}

Market pullback, Bluesky bump, holiday retail survey

.cls-7{fill:#fff;fill-rule:evenodd}

Terry Savage: How did the Dow reach 44,000?

.cls-7{fill:#fff;fill-rule:evenodd}

Click for more